In the present study, we elucidated the important role of INPP4B in inhibiting MM cell line proliferation and chemosensitivity in vitro and revealed that INPP4B was a low risk factor for MM patient in the clinic. This evidence concerns the gene INPP4B and Miyoshi myopathy.